Prevalence of hepatitis C virus infection in patients with antiphospholipid syndrome

Journal of Hepatology

Volumn 30, Issue 5, 1999, Pages 770-773

  Muñoz Rodríguez, Francisco José ^a   Tàssies, Dolors ^a   Font, Josep ^a   Reverter, Joan Carles ^a   Cervera, Ricard ^a   Sánchez Tapias, José Maria ^a   Mazzara, Roberto ^a   Ordinas, Antoni ^a   Ingelmo, Miguel ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Anti 2 glycoprotein I antibodies; Anticardiolipin antibodies; Antiphospholipid antibodies; Antiphospholipid syndrome; Antiprothrombin antibodies; Hepatitis C virus; Lupus anticoagulant

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARDIOLIPIN ANTIBODY; LUPUS ANTICOAGULANT;

ADULT; ANTIBODY DETECTION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PREVALENCE; PRIORITY JOURNAL;

EID: 0038140467     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80127-5     Document Type: Article

References (29)

1. Khamashta MA, Hughes GRV. Antiphospholipid antibodies and antiphospholipid syndrome. Curr Opin Rheumatol. 7:1995;389-394.
2. Font J, Cervera R, López-Soto A, Pallarés L, Bosch X, Ampurdanés S, Casals FJ, et al. Anticardiolipin antibodies in patients with autoimmune diseases: isotype distribution and clinical associations. Clin Rheumatol. 8:1989;475-483.
3. Cervera R, Font J, López-Soto A, Casals F, Pallarés L, Bové A, et al. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis. 49:1990;109-113.
4. Roubey RAS. Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum. 39:1996;1444-1454.
5. Forastiero RR, Martinuzzo ME, Kordich LC, Carreras LO. Reactivity to β2-glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis. Thromb Haemost. 75:1996;717-720.
6. Wong VS, Egner W, Elsey T, Brown D, Alexander GJ. Incidence, character and clinical relevance of mixed cryoglobulinaemia in patients with chronic hepatitis C virus infection. Clin Exp Immunol. 104:1996;25-31.
7. García-Carrasco M, Ramos M, Cervera R, Font J, Vidal J, Mufioz FJ, et al. Hepatitis C virus infection in "primary" Sjögren's syndrome: prevalence and clinical significance in a series of 90 patients. Ann Rheum Dis. 56:1997;173-175.
8. Cacoub P, Musset L, Amoura Z, Guilani P, Chabre H, Lunel F, et al. Anticardiolipin, anti-β2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. J Rheumatol. 24:1997;2139-2144.
9. Biron C, Andréani H, Blanc P, Ramos J, Ducos J, Guigue N, et al. Prevalence of antiphospholipid antibodies in patients with chronic liver disease related to alcohol or hepatitis C virus: correlation with liver injury. J Lab Clin Med. 131:1998;243-250.
10. Asherson RA, Cervera R. Anticardiolipin antibodies, chronic biologic false-positive tests for syphilis and other antiphospholipid antibodies. Wallace DJ, Hahn BP, . Dubois' Lupus Erythematosus. 1993;233-245 Lea & Febiger, Philadelphia.
11. Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis. 46:1987;1-6.
12. Brandt JT, Barna LK, Triplett DA. Laboratory identification of lupus anticoagulants: results of The Second International Work-shop for identification of lupus anticoagulants. Thromb Haemost. 74:1995;1597-1603.
13. Teixidó M, Font J, Reverter JC, Cervera R, Tàssies D, Ingelmo M, et al. Anti-β2-glycoprotein I antibodies: a useful marker for the antiphospholipid syndrome. Br J Rheumatol. 36:1997;113-116.
14. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost. 74:1995;1120-1125.
15. Prieto J, Yuste JR, Beloqui O, Civeira MP, Riezu JI, Aguirre B, et al. Anticardiolipin antibodies in chronic hepatitis C: implication of hepatitis C virus as the cause of the antiphospholipid syndrome. Hepatology. 23:1996;199-204.
16. Horbach DA, Oort EV, Donders RCJM, Derksen RHWM, De Groot PG. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Thromb Haemost. 76:1996;916-924.
17. Wahl DG, Guillemin F, Maistre E, Perret-Guillaume C, Lecompte T, Thibaut G. Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis. Lupus. 7:1998;15-22.
18. Amengual O, Atsumi T, Khamashta MA, Koike T, Hughes GRV. Specificity of ELISA for antibody to β2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol. 35:1996;1239-1243.
19. Tsutsumi A, Matsuura E, Ichikawa K, Fujisaku A, Mukai M, Kobayashi S, et al. Antibodies to β2-glycoprotein I and clinical manifestations in patients with systemic lupus erythematosus. Arthritis Rheum. 39:1996;1466-1474.
20. Leroy V, Arvieux J, Jacob MC, Maynard-Muet M, Baud M, Zarski JP. Prevalence and significance of anticardiolipin, anti-β2-glycoprotein I and anti-prothrombin antibodies in chronic hepatitis C. Br J Haematol. 101:1998;468-474.
21. Quintarelli C, Ferro D, Valesini G, Basili S, Tassone G, Violi F. Prevalence of lupus anticoagulant in patients with cirrhosis: relationship with β2-glycoprotein I plasma levels. J Hepatol. 21:1994;1086-1091.
22. Gervais A, Czernichow B, Grunebaum L, Wiesel ML, Auperin A, Rival-Land D, et al. Anticorps sériques anticardiolipides chez les malades atteints de cirrhose alcoolique. Gastroenterol Clin Biol. 20:1996;736-742.
23. Al-Saeed A, Makris M, Malia RG, Preston FE, Greaves M. The development of antiphospholipid antibodies in haemophilia is linked to infection with hepatitis C. Br J Rheumatol. 88:1994;845-848.
24. Matsuda J, Saitoh N, Gotoh M, Gohchi K, Tsukamoto M, Syoji S, et al. High prevalence of anti-phospholipid antibodies and anti-thyroglobulin antibody in patients with hepatitis C virus infection treated with interferon-α Am J Gastroenterol. 90:1995;1138-1141.
25. Abuaf N, Laperche S, Rajoely B, Carsique R, Deschamps A, Rouquette AM, et al. Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost. 77:1997;856-861.
26. Misra R, Venables PJW, Plater-Zyberke C, Watkins PF, Maini RN. Anticardiolipin antibodies in infectious mononucleosis react with the membrane of activated lymphocytes. Clin Exp Immunol. 75:1989;35-40.
27. Cohen H, Mackie JI, Anagnostopoulos N, Savage GF, Machin SJ. Lupus anticoagulant, anticardiolipin antibodies and human immunodeficiency virus in haemophilia. J Clin Pathol. 42:1989;629-633.
28. Thompson GB. Apoptosis in the pathogenesis and treatment of disease. Science. 267:1995;1456-1462.
29. Casciola-Rosen L, Rosen A, Petri M, Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci USA. 93:1996;1624-1629.